about
NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signalingCharacterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptorModulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4BControl of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturationBiochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activityPartial nucleotide sequencing of six subtype 2c hepatitis C viruses detected in ItalyDetection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube seraGenotyping of hepatitis C virus isolates from Lebanese hemodialysis patients by reverse transcription-PCR and restriction fragment length polymorphism analysis of 5' noncoding regionComparison between the HCV IRES domain IV RNA structure and the Iron Responsive ElementVitamin B12 and hepatitis C: molecular biology and human pathologyScreening of cellular proteins that interact with the classical swine fever virus non-structural protein 5A by yeast two-hybrid analysis.Health care, treatment patterns and cost of services for patients infected with chronic hepatitis C virus in a large insured New England population.Mix-infections with different genotypes of HCV and with HCV plus other hepatitis viruses in patients with hepatitis C in ChinaThe occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinomaSelection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus.Prediction of relapse after interferon therapy in hepatitis C virus-infected patients by the use of triple assay.Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphatesFKBP8 interact with classical swine fever virus NS5A protein and promote virus RNA replication.Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.Current perspectives in hepatitis C.Recent development in the design of antiviral agents.Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co-expressing HCV core protein and CYP2E1.Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons.Synthesis of 9-[1-(substituted)-3-(phosphonomethoxy)propyl]adenine derivatives as possible antiviral agents.HCV RNA in blood donors with isolated reactivities by third-generation RIBA.Association of genetic polymorphism of low-density lipoprotein receptor with chronic viral hepatitis C infection in Han Chinese.Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C.Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease.Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.A Crystal Structure of Classical Swine Fever Virus NS5B Reveals a Novel N-terminal Domain.Prevalence of Infections, HIV Risk Behaviors and Factors Associated with HIV Infection Among Male Injecting Drug Users Attending a Needle/Syringe Exchange Program in Dhaka, Bangladesh
P2860
Q22009551-D900FFC4-4C96-45CF-9757-59F014009F57Q27469307-24515DDC-39AA-4891-8D5C-2FE08B1FDC9EQ27469363-5BF651B0-674C-40E3-9436-49AFFF3DCA10Q27469500-15FF24FF-5BA2-41E2-A8C0-E0A1A44427F6Q27480317-A59D87EF-384F-426F-AC6B-A68DB8F937F9Q27480890-CB8EC01E-B464-4A31-8759-0262C74A4DD1Q27485669-2A71746A-5F78-4144-95EA-BF995E6BD589Q27485714-18714B86-1AC4-4CD1-A48A-49503FF141F4Q27485754-5FF647D3-6EC7-4768-B25A-7FAB47B2DA22Q27487971-63CC12E3-7F56-4566-9122-B28337E10A04Q28362246-3D1D3D1E-3323-480D-9FF1-5278F91A3950Q31150929-D1C7F793-2D82-407D-95E3-42362BA640CDQ34022681-F1D4B617-B0E6-4751-891D-8ABB6762BAC8Q36178576-79CEB344-FF56-4BE4-98F5-753455F67640Q36504707-0E418D3A-92E0-4F71-AE47-CF2FCAFDEE88Q38343422-E03B6CBA-FF3B-489F-9673-F5F2BA5E2862Q38986207-9779F86F-9B34-4401-B0FF-82EF024F9B0EQ39455374-06EB2AC4-76C1-4323-8683-A1BBB21F23B2Q40123480-A1C6E903-7D00-4AE0-BA38-046637E4F3F5Q40573089-2D87E6B0-F5BA-4065-88E4-5CA927180010Q40934419-F9A720D3-D5A8-4B03-85A7-07B512068769Q40943840-7A0AAF34-BE51-42B1-8FE0-F871A5D4B5B6Q42982113-189431A9-3D83-4B12-98ED-2CBE084028E3Q42988770-B0CDAABE-18B6-4E71-8976-8C3240549A7CQ42997853-A78401E7-9FFC-496D-996B-C5832BAA2DCFQ42999596-C5EBB518-7024-4EDA-B375-3D203590B09FQ43030800-0C4565FB-C5CC-4D8A-9AB5-8258F1129C6FQ43038511-5336D61C-CCB7-40E8-A466-D6C9FB9A84F1Q45742035-CAE40E8E-030B-44D3-9292-9AFE5EAAD3C4Q45931918-329F89DE-ABD3-4BAE-B89E-9404030FE07AQ54222571-C2C54AC0-B18A-4584-8087-2F9F93BCA95BQ57928455-1C674356-7E82-4252-B296-D704FB7FD4A1
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Hepatitis C: progress and problems.
@ast
Hepatitis C: progress and problems.
@en
type
label
Hepatitis C: progress and problems.
@ast
Hepatitis C: progress and problems.
@en
prefLabel
Hepatitis C: progress and problems.
@ast
Hepatitis C: progress and problems.
@en
P2860
P356
P1476
Hepatitis C: progress and problems.
@en
P2093
Cuthbert JA
P2860
P304
P356
10.1128/CMR.7.4.505
P407
P577
1994-10-01T00:00:00Z